{"nct_id":"NCT02565576","title":"Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2015-09-29","start_date_type":"ACTUAL","primary_completion_date":"2017-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}